Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
628662
Reference Type
Journal Article
Subtype
Review
Title
Arsenic (+3 oxidation state) methyltransferase and the methylation of arsenicals
Author(s)
Thomas, DJ; Li, J; Waters, SB; Xing, W; Adair, BM; Drobna, Z; Devesa, V; Styblo, M
Year
2007
Is Peer Reviewed?
Yes
Journal
Experimental Biology and Medicine
ISSN:
1535-3702
EISSN:
1535-3699
Volume
232
Issue
1
Page Numbers
3-13
Language
English
PMID
17202581
Web of Science Id
WOS:000243300300002
URL
http://ebm.rsmjournals.com/cgi/content/abstract/232/1/3
Exit
Abstract
Metabolic conversion of inorganic arsenic into methylated products is a multistep process that yields mono-, di-, and trimethylated arsenicals. In recent years, it has become apparent that formation of methylated metabolites of inorganic arsenic is not necessarily a detoxification process. Intermediates and products formed in this pathway may be more reactive and toxic than inorganic arsenic. Like all metabolic pathways, understanding the pathway for arsenic methylation involves identification of each individual step in the process and the characterization of the molecules which participate in each step. Among several arsenic methyltransferases that have been identified, arsenic (+3 oxidation state) methyltransferase is the one best characterized at the genetic and functional levels. This review focuses on phylogenetic relationships in the deuterostomal lineage for this enzyme and on the relation between genotype for arsenic (+3 oxidation state) methyltransferase and phenotype for conversion of inorganic arsenic to methylated metabolites. Two conceptual models for function of arsenic (+3 oxidation state) methyltransferase which posit different roles for cellular reductants in the conversion of inorganic arsenic to methylated metabolites are compared. Although each model accurately represents some aspects of enzyme’s role in the pathway for arsenic methylation, neither model is a fully satisfactory representation of all the steps in this metabolic pathway. Additional information on the structure and function of the enzyme will be needed to develop a more comprehensive model for this pathway.
Keywords
arsenic; methylation; arsenic (+3 oxidation state) methyltransferase
Tags
IRIS
•
Arsenic (Inorganic)
2. Initial Filter
Reviews
Cited in Volume 2a
•
Arsenic Susceptibility
1. Susceptibility Literature Screening
Supplemental Search
2. Excluded
Not Relevant
Life Stages Citation Mapping
10%-15%
•
Inorganic Arsenic (7440-38-2) [Final 2025]
1. Initial Lit Search
PubMed
WOS
ToxNet
3. Initial Filter through Oct 2015
Reviews
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity